Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Bergmann

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|October 15, 2025
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune DiseaseLaura Bucci, Sebastian Böltz, Melanie Hagen, et al.
Annals of the Rheumatic Diseases|May 5, 2023
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cellsChristina Bergmann, Fabian Müller, Jörg H W Distler, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Plos One|February 2, 2018
Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasisNikolai Dyrberg Loft, Lone Skov, Mads Kirchheiner Rasmussen, et al.
Annals of the Rheumatic Diseases|July 2, 2025
Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosisYi-Nan Li, Tim Filla, Andrea-Hermina Györfi, et al.
Nature Communications|July 21, 2021
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagyAriella Zehender, Yi-Nan Li, Neng-Yu Lin, et al.
Nature Communications|August 16, 2018
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosisAriella Zehender, Jingang Huang, Andrea-Hermina Györfi, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Annals of the Rheumatic Diseases|August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Markus Eckstein, Joachim Velden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2024
Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined TherapiesChristina Bergmann, Sara Chenguiti Fakhouri, Thuong Trinh-Minh, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|October 15, 2025
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune DiseaseLaura Bucci, Sebastian Böltz, Melanie Hagen, et al.
Annals of the Rheumatic Diseases|May 5, 2023
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cellsChristina Bergmann, Fabian Müller, Jörg H W Distler, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Plos One|February 2, 2018
Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasisNikolai Dyrberg Loft, Lone Skov, Mads Kirchheiner Rasmussen, et al.
Annals of the Rheumatic Diseases|July 2, 2025
Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosisYi-Nan Li, Tim Filla, Andrea-Hermina Györfi, et al.
Nature Communications|July 21, 2021
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagyAriella Zehender, Yi-Nan Li, Neng-Yu Lin, et al.
Nature Communications|August 16, 2018
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosisAriella Zehender, Jingang Huang, Andrea-Hermina Györfi, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Annals of the Rheumatic Diseases|August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cellsCarlo Tur, Markus Eckstein, Joachim Velden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2024
Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined TherapiesChristina Bergmann, Sara Chenguiti Fakhouri, Thuong Trinh-Minh, et al.
Pageof 11